9月12日，HeartFlow Inc盘中上涨8.02%，报49.14美元/股，成交额5200.65万美元。
消息面上，瑞银近日首次覆盖HeartFlow，给予中性评级及55美元目标价，较当前股价仍有上行空间，提振市场情绪。此前Baird以34美元目标价给予跑赢大盘评级，William Blair同样给予跑赢评级。瑞银目标价显著高于此前分析师平均目标价36.62美元，释放积极信号。
基本面方面，公司Q2调整后每股亏损收窄至0.07美元，大幅优于市场预期的亏损0.13美元；同时将全年收入指引上调至2.46亿至2.50亿美元，远超市场预期的2.30亿美元，连续三个季度上调全年展望，体现AI冠脉疾病诊断业务的强劲增长动能。
HeartFlow成立于2007年，提供AI驱动的冠状动脉疾病诊断与管理软件平台，通过CT血管造影图像生成个性化3D心脏模型，辅助临床决策。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.